PAMELA DOBYNS: Open Payments
NPI 1932867231 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $461 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $127 |
| Neurocrine BioSciences, Inc. | 1 | $39 |
| Indivior Inc. | 2 | $38 |
| Gilead Sciences, Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: LYBALVI, INGREZZA, SUBLOCADE, ABILIFY ASIMTUFII, ARISTADA.
Industry payments across CO — which companies pay providers there.
